Table 2.
Summary of feline pathological or pathophysiological conditions in which increases in APPs have been reported
| Disease | Increased APP | Reference |
|---|---|---|
| Anemia of inflammatory diseases (localised purulent infections) | Hp, AGP | Ottenjann et al. (2006) |
| Diabetes | SAA | Sasaki et al. (2003) |
| Experimental inflammation | Hp, SAA, AGP | Harvey and Gaskin (1978), Kajikawa et al. (1999) |
| Feline coronavirus (FCoV) infection (non-symptomatic) | AGP⁎ | Ceciliani et al., 2004, Giordano et al., 2004, Paltrinieri et al. (2006), Paltrinieri et al. (2007a) |
| Feline calicivirus infection | AGP | TerWee et al. (1997) |
| Feline chlamydiosis | AGP | TerWee et al. (1998) |
| Feline leukaemia virus (FeLV) | AGP | Duthie et al. (1997) |
| Feline infectious peritonitis | Hp, SAA, AGP⁎ | Harvey and Gaskin, 1978, Bence et al., 2005, Duthie et al., 1997, Giordano et al., 2004, Kaijkawa et al. (1999), Paltrinieri et al. (2007a), Stoddart et al. (1988) |
| Feline immunodeficiency virus (FIV) | AGP | Duthie et al. (1997) |
| Hospitalisation | Hp, SAA, AGP | Kajikawa et al. (1999) |
| Infectious diseases (miscellaneous) | Hp, AGP, SAA | Harvey and Gaskin, 1978, Sasaki et al., 2003, Hansen et al., 2006, Paltrinieri et al. (2007a) |
| Injury | SAA | Sasaki et al. (2003) |
| Lymphoma | AGP | Correa et al. (2001) |
| Oriental and Abyssinian cats (healthy and with amyloidosis) | SAA⁎ | DiBartola et al. (1989) |
| Renal failure | SAA | Sasaki et al. (2003) |
| Splenectomy | Hp | Harvey and Gaskin (1978) |
| Surgery | Hp, SAA, AGP | Kajikawa et al. (1999), Sasaki et al. (2003) |
| Tumours | AGP | Selting et al. (2000), Sasaki et al. (2003) |
| Urinary tract diseases | SAA | Sasaki et al. (2003) |
Structural changes also reported.